Format

Send to

Choose Destination
Cancer Epidemiol Biomarkers Prev. 2016 Apr;25(4):721-4. doi: 10.1158/1055-9965.EPI-15-1290. Epub 2016 Feb 9.

Cutaneous Human Papillomaviruses and Squamous Cell Carcinoma of the Skin: Nested Case-Control Study.

Author information

1
Department of Laboratory Medicine, Division of Pathology, Karolinska Institute, Stockholm, Sweden.
2
Department of Occupational and Environmental Medicine, Lund University, Lund, Sweden.
3
Department of Laboratory Medicine, Division of Pathology, Karolinska Institute, Stockholm, Sweden. Finnish Cancer Registry, Helsinki, Finland.
4
Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.
5
Department of Laboratory Medicine, Division of Pathology, Karolinska Institute, Stockholm, Sweden. Joakim.Dillner@ki.se.

Abstract

BACKGROUND:

Cutaneous human papillomavirus (HPV) types have been associated with non-melanoma skin cancer (NMSC), including a previous nested case-control study using HPV serology with bacterially derived fusion proteins with the major HPV capsid protein L1 (GST-L1). However, HPV serology using conformationally intact pseudovirions has been shown to correlate better with natural infection. Prospective studies using a more valid marker of infection are therefore warranted.

METHODS:

Cancer registry follow-up of large Nordic biobanks identified prediagnostic serum samples from 633 subjects who later developed SCC, 1,990 subjects who developed basal cell carcinoma (BCC). The samples from cases and matched controls were tested for IgG to pseudovirions to 16 different HPV types (3, 5, 6, 11, 15: , 16, 18, 31, 32, 33, 38: , 45, 52, 58, 68, and 76: ) and two polyomaviruses (MCPyV and JCPyV).

RESULTS:

Baseline seropositivity was not associated with SCC risk, and there were only weak associations with BCC risk [HPV-5 (OR, 1.1; 95% confidence interval [CI], 1.0-1.3), HPV-15 (OR, 1.2; 95% CI, 1.0-1.4), HPV-38 (OR, 1.2; 95% CI, 1.0-1.3), and MCPyV (OR, 1.1; 95% CI, 1.0-1.3)]. Acquisition of HPV-5 seropositivity during follow-up was associated with SCC risk (OR, 3.2; 95% CI, 1.3-7.6). Persistent seropositivity for HPV-15 was weakly associated with BCC (OR, 1.4; 95% CI, 1.0-1.9) and HPV-6 antibody persistence was weakly associated with SCC (OR, 2.2; 95% CI, 1.0-4.8).

CONCLUSION:

Considering the large number of viruses tested, the weak associations found do not support any strong links between studied HPV and NMSC, with the possible exception of HPV-5 seroconversion and SCC.

IMPACT:

Known alpha and beta papillomaviruses do not appear to be risk factors for NMSC. Cancer Epidemiol Biomarkers Prev; 25(4); 721-4. ©2016 AACR.

PMID:
26908428
DOI:
10.1158/1055-9965.EPI-15-1290
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center